EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Century Therapeutics, Inc. (IPSC) had EBIT Margin of 67.95% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$109.16M |
|
$76.56M |
|
-- |
|
$109.16M |
|
$34.99M |
|
$74.18M |
|
$2.38M |
|
$76.56M |
|
$76.56M |
|
$76.56M |
|
$76.56M |
|
$76.56M |
|
$76.56M |
|
$74.18M |
|
$76.54M |
|
86.02M |
|
86.10M |
|
$0.89 |
|
$0.89 |
|
| Balance Sheet Financials | |
$169.63M |
|
$59.53M |
|
$145.98M |
|
$315.61M |
|
$14.50M |
|
-- |
|
$60.67M |
|
$75.17M |
|
$240.44M |
|
$206.24M |
|
$240.44M |
|
86.15M |
|
| Cash Flow Statement Financials | |
$-34.62M |
|
$27.93M |
|
$0.12M |
|
$61.21M |
|
$54.64M |
|
$-6.57M |
|
$2.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
67.95% |
|
|
EBIT Margin |
67.95% |
-- |
|
70.13% |
|
70.13% |
|
$-35.10M |
|
-- |
|
-- |
|
-- |
|
0.35 |
|
-- |
|
-- |
|
-- |
|
31.84% |
|
37.12% |
|
24.26% |
|
31.84% |
|
$2.79 |
|
$-0.41 |
|
$-0.40 |
|